Top Midday Decliners

MT Newswires Live11-15

Calidi Biotherapeutics (CLDI) said Thursday it has priced its offering of about 4.44 million shares at $1.69 apiece, targeting gross proceeds of $7.5 million.

The company intends to use the net proceeds for working capital, general corporate purposes, and pre-clinical and clinical trials.

Shares slumped 36% intraday.

Bragg Gaming (BRAG) reported higher Q3 revenue and concluded a strategic review, saying that ongoing execution of its strategy best option to maximize shareholder value. The company also said it is "currently tracking to the lower end of guidance" for 2024.

Shares sank 27% as intraday trading volume jumped to over 461,000 versus a daily average of about 32,000.

Chardan downgraded Allurion Technologies (ALUR) to neutral from buy following Q3 results released Wednesday.

Shares of Allurion sank 25% as intraday trading volume climbed to more than 684,000 from a daily average of roughly 186,000.

Price: 2.18, Change: -1.20, Percent Change: -35.50

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment